1. Home
  2. POAI vs LICN Comparison

POAI vs LICN Comparison

Compare POAI & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • LICN
  • Stock Information
  • Founded
  • POAI 2002
  • LICN 2004
  • Country
  • POAI United States
  • LICN China
  • Employees
  • POAI N/A
  • LICN N/A
  • Industry
  • POAI Industrial Specialties
  • LICN
  • Sector
  • POAI Health Care
  • LICN
  • Exchange
  • POAI Nasdaq
  • LICN Nasdaq
  • Market Cap
  • POAI 9.7M
  • LICN 8.7M
  • IPO Year
  • POAI N/A
  • LICN 2023
  • Fundamental
  • Price
  • POAI $1.45
  • LICN $0.07
  • Analyst Decision
  • POAI Hold
  • LICN
  • Analyst Count
  • POAI 1
  • LICN 0
  • Target Price
  • POAI N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • POAI 483.7K
  • LICN 30.4M
  • Earning Date
  • POAI 03-27-2025
  • LICN 12-31-2024
  • Dividend Yield
  • POAI N/A
  • LICN N/A
  • EPS Growth
  • POAI N/A
  • LICN 36.90
  • EPS
  • POAI N/A
  • LICN 0.28
  • Revenue
  • POAI $1,484,223.00
  • LICN $41,929,000.00
  • Revenue This Year
  • POAI N/A
  • LICN N/A
  • Revenue Next Year
  • POAI $569.48
  • LICN N/A
  • P/E Ratio
  • POAI N/A
  • LICN $0.28
  • Revenue Growth
  • POAI N/A
  • LICN 24.86
  • 52 Week Low
  • POAI $0.55
  • LICN $0.06
  • 52 Week High
  • POAI $3.67
  • LICN $2.44
  • Technical
  • Relative Strength Index (RSI)
  • POAI 50.83
  • LICN 29.78
  • Support Level
  • POAI $1.39
  • LICN $0.06
  • Resistance Level
  • POAI $1.97
  • LICN $0.08
  • Average True Range (ATR)
  • POAI 0.14
  • LICN 0.01
  • MACD
  • POAI -0.02
  • LICN 0.02
  • Stochastic Oscillator
  • POAI 14.88
  • LICN 56.39

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About LICN Lichen China Limited

Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.

Share on Social Networks: